tiprankstipranks
Advertisement
Advertisement

RNAZ Stock Latest News

Transcode Therapeutics files to sell 1.53M shares of common stock for holders
The FlyTranscode Therapeutics files to sell 1.53M shares of common stock for holders
6d ago
RNAZ
Transcode Therapeutics files to sell 15.96M shares of common stock for holders
PremiumThe Fly
Transcode Therapeutics files to sell 15.96M shares of common stock for holders
6d ago
RNAZ
Transcode Therapeutics appoints Anna Moore as Chair of Scientific Advisory
PremiumThe Fly
Transcode Therapeutics appoints Anna Moore as Chair of Scientific Advisory
10d ago
RNAZ
Transcode Therapeutics signs research agreement with Michigan State University
PremiumThe Fly
Transcode Therapeutics signs research agreement with Michigan State University
10d ago
RNAZ
Transcode Therapeutics signs flexible financing agreement for up to $20M
PremiumThe Fly
Transcode Therapeutics signs flexible financing agreement for up to $20M
30d ago
RNAZ
TransCode Therapeutics Secures New Financing to Extend Runway
PremiumCompany AnnouncementsTransCode Therapeutics Secures New Financing to Extend Runway
30d ago
8K
RNAZ
TransCode Therapeutics Delays 2025 Annual Filing
Premium
Company Announcements
TransCode Therapeutics Delays 2025 Annual Filing
1M ago
RNAZ
TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal
Premium
Company Announcements
TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal
2M ago
8K
RNAZ
Transcode Therapeutics enters exclusive license agreement with Unleash
PremiumThe Fly
Transcode Therapeutics enters exclusive license agreement with Unleash
2M ago
RNAZ
TransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy
PremiumCompany Announcements
TransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy
2M ago
8K
RNAZ
TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial
PremiumCompany Announcements
TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial
3M ago
8K
RNAZ
Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138
PremiumThe Fly
Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138
3M ago
RNAZ
TransCode Therapeutics reports promising preclinical glioblastoma results
PremiumCompany AnnouncementsTransCode Therapeutics reports promising preclinical glioblastoma results
4M ago
8K
RNAZ
Transcode Therapeutics announces publication of data supporting TTX-MC138
Premium
The Fly
Transcode Therapeutics announces publication of data supporting TTX-MC138
4M ago
RNAZ
TransCode Therapeutics Strengthens Board with Veteran Financial Expert
Premium
Company Announcements
TransCode Therapeutics Strengthens Board with Veteran Financial Expert
5M ago
8K
RNAZ
TransCode Announces Collaboration for Phase 2a Trial
PremiumCompany Announcements
TransCode Announces Collaboration for Phase 2a Trial
5M ago
8K
RNAZ
Transcode, Quantum Leap announce new collaboration to study TTX-MC138
PremiumThe Fly
Transcode, Quantum Leap announce new collaboration to study TTX-MC138
5M ago
RNAZ
TransCode Therapeutics Amends Preferred Stock Designation
PremiumCompany Announcements
TransCode Therapeutics Amends Preferred Stock Designation
6M ago
8K
RNAZ
TransCode Therapeutics Completes Phase 1a Trial for TTX-MC138
PremiumCompany Announcements
TransCode Therapeutics Completes Phase 1a Trial for TTX-MC138
7M ago
8K
RNAZ
Transcode Therapeutics’ TTX-MC138 achieves safety endpoint in Phase 1a study
PremiumThe FlyTranscode Therapeutics’ TTX-MC138 achieves safety endpoint in Phase 1a study
7M ago
RNAZ
TransCode Therapeutics Acquires Polynoma and Secures Investment
Premium
Company Announcements
TransCode Therapeutics Acquires Polynoma and Secures Investment
7M ago
8K
RNAZ
Transcode Therapeutics Inc trading resumes
Premium
The Fly
Transcode Therapeutics Inc trading resumes
7M ago
RNAZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >